Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine
نویسندگان
چکیده
This study reports on L-carnosine phytosomes as an alternative for the prodrug N-acetyl-L-carnosine as a novel delivery system to the lens. L-carnosine was loaded into lipid-based phytosomes and hyaluronic acid (HA)-dispersed phytosomes. L-carnosine-phospholipid complexes (PC) of different molar ratios, 1:1 and 1:2, were prepared by the solvent evaporation method. These complexes were characterized with thermal and spectral analyses. PC were dispersed in either phosphate buffered saline pH 7.4 or HA (0.1% w/v) in phosphate buffered saline to form phytosomes PC1:1, PC1:2, and PC1:2 HA, respectively. These phytosomal formulations were studied for size, zeta potential, morphology, contact angle, spreading coefficient, viscosity, ex vivo transcorneal permeation, and cytotoxicity using primary human corneal cells. L-carnosine-phospholipid formed a complex at a 1:2 molar ratio and phytosomes were in the size range of 380-450 nm, polydispersity index of 0.12-0.2. The viscosity of PC1:2 HA increased by 2.4 to 5-fold compared with HA solution and PC 1:2, respectively; significantly lower surface tension, contact angle, and greater spreading ability for phytosomes were also recorded. Ex vivo transcorneal permeation parameters showed significantly controlled corneal permeation of L-carnosine with the novel carrier systems without any significant impact on primary human corneal cell viability. Ex vivo porcine lenses incubated in high sugar media without and with L-carnosine showed concentration-dependent marked inhibition of lens brunescence indicative of the potential for delaying changes that underlie cataractogenesis that may be linked to diabetic processes.
منابع مشابه
Comparison of hyaluronic acid-containing topical eye drops with carbomer-based topical ocular gel as a tear replacement in canine keratoconjunctivitis sicca: A prospective study in twenty five dogs
The aim of this study was to evaluate the efficacy of a hyaluronic acid containing eye drop in ameliorating ocular surface pathology and discomfort in canine keratoconjunctivitis sicca (KCS). Twenty five dogs with KCS treated with a topical carbomer (CA)-based tear replacement gel were moved to treatment with a hyaluronic acid (HA)-containing tear replacement eye drop. Dogs were subject to a fu...
متن کاملTarget Specific and Long-Acting Delivery of Biopharmaceuticals Using Hyaluronic Acid Derivatives
Statement of Purpose: Hyaluronic acid (HA) is a biodegradable, biocompatible, non-immunogenic, nontoxic, and non-inflammatory linear polysaccharide. HA has been used for various medical applications such as arthritis treatment, ocular surgery, tissue augmentation, drug delivery and tissue engineering [1]. In this work, HA has been extensively investigated as novel drug carriers for target speci...
متن کاملChitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration
Pharmaceutical approaches based on nanotechnologies and the development of eye drops composed of the mucoadhesive polymers chitosan and hyaluronic acid are emerging strategies for the efficient treatment of ocular diseases. These innovative nanoparticulate systems aim to increase drugs' bioavailability at the ocular surface. For the successful development of these systems, the evaluation of muc...
متن کاملExtended Ocular Drug Delivery using Hyaluronic Acid-containing model Silicone Hydrogel Materials
84 ©2013 Society For Biomaterials
متن کاملEvaluation of Biocompatibility and Release Profile of Ginger Extract Loaded Hyaluronic Acid Nanocapsules for Medical Applications
Introduction: Ginger is a plant that is used as a drug for pain relieving and anti-inflammatory in traditional medicine, but conventional prescribing of it faces serious challenges. One way to overcome these problems is the loading of ginger extract in polymer carriers. The aim of this study was characterization and evaluation of the loading and releasing of ginger extract from hyaluronic acid ...
متن کامل